CMTM6 mediates the Warburg effect and promotes the liver metastasis of colorectal cancer
2
조회
0
다운로드
0
인용
0
참고문헌
초록
Liver metastasis of colorectal cancer (CRC) is a leading cause of death among cancer patients. The overexpression of glucose transporter 1 (Glut1) and enhanced glucose uptake that are associated with the Warburg effect are frequently observed in CRC liver metastases, but the underlying mechanisms remain poorly understood. CKLF-like MARVEL transmembrane domain-containing protein 6 (CMTM6) regulates the intracellular trafficking of programmed death-ligand-1 (PD-L1); therefore, we investigated whether CMTM6 regulates Glut1 trafficking and the Warburg effect in CRC cells. We found that knocking down of CMTM6 by shRNA induced the lysosomal degradation of Glut1, decreased glucose uptake and glycolysis in CRC cells, and suppressed subcutaneous CRC growth in nude mice and liver metastasis in C57BL/6 mice. Mechanistically, CMTM6 forms a complex with Glut1 and Rab11 in the endosomes of CRC cells, and this complex is required for the Rab11-dependent transport of Glut1 to the plasma membrane and for the protection of Glut1 from lysosomal degradation. Multiomics revealed global transcriptomic changes in CMTM6-knockdown CRC cells that affected the transcriptomes of adjacent cancer-associated fibroblasts from CRC liver metastases. As a result of these transcriptomic changes, CMTM6-knockdown CRC cells exhibited a defect in the G2-to-M phase transition, reduced secretion of 60 cytokines/chemokines, and inability to recruit cancer-associated fibroblasts to support an immunosuppressive CRC liver metastasis microenvironment. Analysis of TCGA data confirmed that CMTM6 expression was increased in CRC patients and that elevated CMTM6 expression was associated with worse patient survival. Together, our data suggest that CMTM6 plays multiple roles in regulating the Warburg effect, transcriptome, and liver metastasis of CRC.
Abstract
Liver metastasis of colorectal cancer (CRC) is a leading cause of death among cancer patients. The overexpression of glucose transporter 1 (Glut1) and enhanced glucose uptake that are associated with the Warburg effect are frequently observed in CRC liver metastases, but the underlying mechanisms remain poorly understood. CKLF-like MARVEL transmembrane domain-containing protein 6 (CMTM6) regulates the intracellular trafficking of programmed death-ligand-1 (PD-L1); therefore, we investigated whether CMTM6 regulates Glut1 trafficking and the Warburg effect in CRC cells. We found that knocking down of CMTM6 by shRNA induced the lysosomal degradation of Glut1, decreased glucose uptake and glycolysis in CRC cells, and suppressed subcutaneous CRC growth in nude mice and liver metastasis in C57BL/6 mice. Mechanistically, CMTM6 forms a complex with Glut1 and Rab11 in the endosomes of CRC cells, and this complex is required for the Rab11-dependent transport of Glut1 to the plasma membrane and for the protection of Glut1 from lysosomal degradation. Multiomics revealed global transcriptomic changes in CMTM6-knockdown CRC cells that affected the transcriptomes of adjacent cancer-associated fibroblasts from CRC liver metastases. As a result of these transcriptomic changes, CMTM6-knockdown CRC cells exhibited a defect in the G2-to-M phase transition, reduced secretion of 60 cytokines/chemokines, and inability to recruit cancer-associated fibroblasts to support an immunosuppressive CRC liver metastasis microenvironment. Analysis of TCGA data confirmed that CMTM6 expression was increased in CRC patients and that elevated CMTM6 expression was associated with worse patient survival. Together, our data suggest that CMTM6 plays multiple roles in regulating the Warburg effect, transcriptome, and liver metastasis of CRC.
참고문헌 (50)
- Tsilimigras, D. I., "Liver metastases", Nat. Rev. Dis. Prim, 7, pp.27~ (2021)
- Faubert, B., "Metabolic reprogramming and cancer progression", Science, 368, pp.eaaw5473~ (2020)
- Yang, F., "Metabolic reprogramming and its clinical implication for liver cancer", Hepatology, 78, pp.1602~1624 (2023)
- Vander Heiden, M. G., "Understanding the War burg effect : the metabolic requirements of cell proliferation", Science, 324, pp.1029~1033 (2009)
- Potter, M., "The Warburg effect : 80 years on", Biochem Soc. Trans, 44, pp.1499~1505 (2016)
- fluorodeoxyglucose accumulation in liver cancer, "Oncol. Rep", 2014, 701~706
- Akiyoshi, T., "Comparison of preoperative whole-body positron emission tomography with MDCT in patients with primary colorectal cancer", Colorectal Dis, 11, pp.464~469 (2009)
- Szablewski, L., "Expression of glucose transporters in cancers", Biochim. Biophys. Acta, 1835, pp.164~169 (2013)
- Haber, R. S., "GLUT1 glucose transporter expression in colorectal carcinoma : a marker for poor prognosis", Cancer, 83, pp.34~40 (1998)
- Cooper, R., "Glucose transporter-1 (GLUT-1): a potential marker of prognosis in rectal carcinoma?", Br. J. Cancer, 89, pp.870~876 (2003)
- Wieman, H. L., "Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase", Akt regulation of Glut1 activity and trafficking, 2007, pp.18, 1437~1446
- Cohen, M., "Live imaging of GLUT2 glucose-dependent trafficking and its inhibition in polarized epithelial cysts", Open Biol, 4, pp.140091~ (2014)
- Uhlig, M., "Functional role of Rab11 in GLUT4 trafficking in cardiomyocytes", Mol. Cell Endocrinol, 235, pp.1~9 (2005)
- Du, W., "IFN-gamma", mTORC1 decreased Rab11 in Schwann cells of diabetic peripheral neuropathy, inhibiting cell proliferation via GLUT1 downregulation, 2020, pp.235, 5764~5776
- Wang, Y., "Targeting Src SH3 domain-mediated glycolysis of HSC suppresses transcriptome, myofibroblastic activation, and colorectal liver metastasis", Hepa tology (2024)[DOI]
- Wu, J., "CMTM family proteins 1-8 : roles in cancer biological processes and potential clinical value", Cancer Biol. Med, 17, pp.528~542 (2020)
- Burr, M. L., "CMTM6 maintains the expression of PD-L1 and regulates anti tumour immunity", Nature, 549, pp.101~105 (2017)
- Mezzadra, R., "Identification of CMTM6 and CMTM4 as PD-L1 protein reg ulators", Nature, 549, pp.106~110 (2017)
- Gao, H., "CMTM6 as a potential therapy target is associated with immuno logical tumor microenvironment and can promote migration and invasion in pancreatic adenocarcinoma", Funct. Integr. Genomics, 23, pp.306~ (2023)
- Wei, L., "CMTM6 knockdown prevents glioma pro gression by inactivating the mTOR pathway", Ann. Transl. Med, 10, pp.181~ (2022)
- Chen, L., "Targeting CMTM6 Suppresses Stem Cell-like Properties And Enhances Antitumor Immunity In Head And Neck Squamous Cell Carcinoma", Cancer Immunol. Res, 8, pp.179~191 (2020)
- Huang, X., "CMTM6 as a candidate risk gene for cervical cancer : Compre hensive bioinformatics study", Front Mol. Biosci, 9, pp.983410~ (2022)
- Liu, Q., "CMTM6 promotes hepatocellular carcinoma progression through stabilizing beta-catenin", Cancer Lett, 583, pp.216585~ (2023)
- Huang, X., "CMTM6 promotes migration, invasion, and EMT by interacting with and stabilizing vimentin in hepatocellular carcinoma cells", J. Transl. Med, 19, pp.120~ (2021)
- Huang, Y., "CMTM6 inhibits tumor growth and reverses chemoresistance by preventing ubiquitination of p21 in hepatocellular carcinoma", Cell Death Dis, 13, pp.251~ (2022)
- Liu, C., "IQGAP1 suppresses TbetaRII-mediated myofibroblastic activation and metastatic growth in liver", J. Clin. Invest, 123, pp.1138~1156 (2013)
- Dou, C., "P300 acetyltransferase mediates stiffness-induced activation of hepatic stellate cells into tumor-promoting myofibroblasts", Gastroenterology, 154, pp.2209~2221 (2018)
- Wang, Y., "p300 acetyltransferase is a cytoplasm-to-nucleus shuttle for SMAD2", 3 and TAZ nuclear transport in transforming growth factor beta stimulated hepatic stellate cells, 2019, pp.70, 1409~1423
- Kang, N., "Focal adhesion assembly in myofibroblasts fosters a micro environment that promotes tumor growth", Am. J. Pathol, 177, pp.1888~1900 (2010)
- Decker, N. K., "Nitric oxide regulates tumor cell cross-talk with stromal cells in the tumor microenvironment of the liver", Am. J. Pathol, 173, pp.1002~1012 (2008)
- Chen, Y., "Focal adhesion kinase promotes hepatic stellate cell activation by regulating plasma membrane localization of TGFbeta receptor 2", Hepatol. Com mun, 4, pp.268~283 (2020)
- Liu, D., "Protein diaphanous homolog 1(Diaph1)promotes myofibroblastic activation of hepatic stellate cells by regulating Rab5a activity and TGFbeta receptor endocytosis", FASEB J, 34, pp.7345~7359 (2020)
- Sun, L., "PD-L1 promotes myofibroblastic activation of hepatic stellate cells by distinct mechanisms selective for TGF-beta receptor I versus II", Cell Rep, 38, pp.110349~ (2022)
- Tu, K., "Vasodilator-stimulated phosphoprotein promotes activation of hepatic stellate cells by regulating Rab11-dependent plasma membrane target ing of transforming growth factor beta receptors", Hepatology, 61, pp.361~374 (2015)
- Liu, C., "PDGF receptor-alpha promotes TGF-beta signaling in hepatic stellate cells via transcriptional and posttranscriptional regulation of TGF-beta receptors", Am. J. Physiol. Gastrointest. Liver Physiol, 307, pp.G749~G759 (2014)
- Kang, N., "Membrane-to-nucleus signals and epigenetic mechanisms for myofibroblastic activation and desmoplastic stroma: Potential therapeutic targets for liver metastasis?", Mol. cancer Res, 13, pp.604~612 (2015)
- Affo, S., "Promotion of cholangiocarcinoma growth by diverse cancer associated fibroblast subpopulations", Cancer Cell, 39, pp.866~882 (2021)
- Bhattacharjee, S., "Tumor restriction by type I collagen opposes tumor promoting effects of cancer-associated fibroblasts", J. Clin. Invest, 131, pp.e146987~ (2021)
- Wan, P., "Guidance receptor promotes the asymmetric distribution of exocyst and recycling endosome during collective cell migration", Development, 140, pp.4797~4806 (2013)
- Butterworth, M. B., "Rab11b regulates the trafficking and recycling of the epithelial sodium channel(ENaC)", Am. J. Physiol. Ren. Physiol, 302, pp.F581~F590 (2012)
- Grant, B. D., "Pathways and mechanisms of endocytic recycling", Nat. Rev. Mol. Cell Biol, 10, pp.597~608 (2009)
- Takahashi, S., "Rab11 regulates exocytosis of recycling vesicles at the plasma membrane", J. Cell Sci, 125, pp.4049~4057 (2012)
- Campa, C. C., "Rab11 activity and PtdIns(3)P turnover removes recycling cargo from endosomes", Nat. Chem. Biol, 14, pp.801~810 (2018)
- Chakravarthy, A., "TGF-beta associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure", Nat. Commun, 9, pp.4692~ (2018)
- Jenkins, L., "Cancer-associated fibroblasts suppress CD8+ T-cell infiltration and confer resistance to immune-checkpoint blockade", Cancer Res, 82, pp.2904~2917 (2022)
- Kang, N., "Hepatic stellate cells: partners in crime for liver metastases?", Hepatology, 54, pp.707~713 (2011)
- Fischer von Mollard, G., "Rab proteins in regulated exocytosis", Trends Biochem Sci, 19, pp.164~168 (1994)
- Escrevente, C., "Rab11 is required for lysosome exocytosis through the interaction with Rab3a, Sec15 and GRAB", J. Cell Sci, 134, pp.jcs246694~ (2021)
- Darchen, F., "Multiple aspects of Rab protein action in the secretory pathway : Focus on Rab3 and Rab6", Biochimie, 82, pp.375~384 (2000)
- Ohnishi, H., "Involvement of Rab4 in regulated exocytosis of rat pancreatic acini", Gastroenterology, 116, pp.943~952 (1999)